DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
7 articles
A new experimental mRNA vaccine is trying to solve one of Ebola’s hardest problems: protection that does not collapse when a different viral strain appears.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
A new preclinical study changes an old assumption: for mRNA vaccines, the key is not only which antigen is delivered, but where the body expresses it.
Researchers at MIT modified lipid nanoparticles with aromatic compounds.
mRNA cancer vaccines show promise but face years of trials—progress isn’t the same as proven therapy.
DoriVac’s folded DNA nanostructures just hit 2x the T-cell response of mRNA in early trials—without the deep-freeze logistics.
A new amino acid formulation appears to improve LNP uptake in cells, though no human data yet exists.
